Assessing the use of navigators for improvement of patient adherence to onabotulinumtoxinA

“We really felt that this was an important question to ask because we know that OAB therapy adherence is associated with improvements in urinary symptoms, quality of life, and decreased OAB-related health care costs,” says Ekene Enemchukwu, MD, MPH.

Read the full article here

Related Articles